NYSE: BMY · Drug Manufacturers - General
Over the past week, Bristol-Myers Squibb (BMY) racked up about 111 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 33% bullish across the tracked sources. Wall Street is roughly in line with the crowd, with 10 of 28 analysts rating BMY a buy.
There is little buzz around BMY this week and broad agreement on direction, which is why it reads as a Sell.
Wall Street’s 36% buy share sits next to a crowd that ranges from X at 28% to News at 38%. No other tracker puts the two side by side.
Across 28 analysts the consensus is a Hold: 10 buy calls against 1 sell, with an average 12-month price target of $65.92.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is mixed and the 3 sources broadly agree, so the read is a Sell.
Wall Street’s 36% buy share lands almost exactly on the crowd average of 33%. The split is inside the crowd: News reads 38% bullish while X sits at 28%, a 10-point spread that single-source trackers miss.
Over the 30-day window, Bristol-Myers Squibb (BMY) buzz held subdued around 37.7 while the price drifted down 6.1% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 13.1M shares. Updated Oct 10, 2026. Over the last 7 trading days, BMY lost 2.8%. Buzz activity in the recent week averaged 43.3 and was variable, swinging between 32.5 and 53.1. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 18 of the 21 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for BMY and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live BMY sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Oct 10, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Hold (10 / 17 / 1) |
| Crowd bullish (7d) | 33% |
| Avg price target | $65.92 |
| Most bullish source | News, 38% |
| Most bearish source | X, 28% |
| Sentiment spread | 10 pts |
| Mentions (7d) | 111 |
| Market cap | $121.7B |
| P/E · Forward P/E | 13.1 · 9.4 |
| EPS · Beta | $4.54 · 0.2 |
| Revenue (TTM) | $49.19B · 19% margin |
| Industry | Drug Manufacturers - General |
Based on aggregated sentiment from Reddit, X and News sources, Bristol-Myers Squibb (BMY) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 33% bullish across 3 active sources. Those sources contribute 111 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Bristol-Myers Squibb (BMY) is fairly quiet with 6 mentions over the last 7 days; the 30-day context spans 9 tracked subreddits. The 7-day tone is 33% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bearish on Bristol-Myers Squibb (BMY), averaging 33% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 38% bullish and X at 28%, a 10-point spread. On the professional side, 10 of 28 analysts rate BMY a buy.
Of the 28 analysts covering Bristol-Myers Squibb (BMY), 10 rate it a buy, 17 a hold and 1 a sell, for a hold consensus. The average price target is $65.92. That lines up with the crowd average of 33% bullish.
Bristol-Myers Squibb (BMY)'s cross-source average is bearish at 33% bullish. All 3 tracked sources lean bearish. Reddit reads 33% bullish, News reads 38% bullish and x coverage is the most negative at 28% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Bristol-Myers Squibb (BMY) at 33% bullish. All 3 tracked sources lean bearish. The most bearish reading is x at 28% bullish. 3-day activity momentum is falling on X, while news activity is rising. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 61 mentions (55% of total volume). News contributes 44 mentions and Reddit contributes 6 mentions. The cross-source average is bearish at 33% bullish, while news is the only source with rising 3-day activity. All 3 tracked sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. BMY's sell signal at 93/100 conviction reflects a bearish cross-source average at 33% bullish. All 3 tracked sources lean bearish. It is a research shortcut, not financial advice.
The BMY sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key